Eckert & Ziegler SE (LON:0NZY)

Market Cap	795.85M -15.3%
Revenue (ttm)	265.76M +9.6%
Net Income	34.70M +35.3%
EPS	0.55 +34.6%
Shares Out	n/a
PE Ratio	22.94
Forward PE	17.26
Dividend	0.14 (0.92%)
Ex-Dividend Date	Jun 19, 2025

Volume	716
Average Volume	26,865
Open	15.28
Previous Close	15.19
Day's Range	14.77 - 15.24
52-Week Range	14.11 - 23.07
Beta	1.71
RSI	41.44
Earnings Date	Mar 26, 2026

About Eckert & Ziegler SE

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-co...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1992
• Employees: 1,112
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0NZY

Financial Performance

In 2024, Eckert & Ziegler SE's revenue was 295.85 million, an increase of 20.22% compared to the previous year's 246.09 million. Earnings were 33.28 million, an increase of 26.52%.

Financial numbers in EUR